It’s been over a year since the House of Representatives approved Carly’s Law in Alabama. This bill allowed testing of cannabidiol for treatment of children with severe seizures. Since the passage of this law, some of Alabama’s severest epilepsy patients gained access to clinical trials and began using the the oil. Although it’s only been 6 months into trials, promising results are emerging as doctors are pleased with what they are observing. […]
Dr. Nora Volkow, director of the National Institute on Drug Abuse, recently stepped forward to help clarify some of the misinformation circling marijuana and cannabidiol. As one of the world’s top experts on the application and misuse of cannabis and research, Volkow believes “what we can say with certainty is that cannabis contains active ingredients with potential therapeutic properties. […]
Last Friday, Michigan’s Medical Marijuana Review Panel voted to add autism to the list of qualifying conditions fit for treatment under state law.
Mike Zimmer, director of the Michigan Department of Licensing and Regulatory Affairs, is the next step in the process for approval. Zimmer has until late October to make a final decision. Once a final determination is made it will be announced on the agency’s website. […]
In the U.S. military, the U.S. Department of Veterans Affairs estimates that in Operations Iraqi Freedom and Enduring Freedom, about 11-20 out of every 100 Veterans (or between 11-20%) who served in these operations have PTSD in a given year. Additionally, about 12 out of every 100 Gulf War Veterans (or 12%) have PTSD in a given year.
Post-traumatic stress disorder (PTSD) can occur after you have been through any significant trauma. A trauma is an alarming and often terrifying event that you see or experience. Going through trauma is not rare, although only a small portion of people who have experienced trauma actually develop PTSD. It is estimated that about 8 million adults have PTSD in a given year.
While PTSD is a severe mental health condition, there is currently an insufficient emphasis on effective medications for PTSD patients. Additionally, the medications that are currently recommended for PTSD provide limited efficacy. […]
Over the past few months, from local community halls to Capitol Hill, one thing has been made clear: there is an outcry of support in favor of more research on CBD and medical marijuana. Proponents of CBD oil state that removing these barriers to research is the only clear way to market something so significant to families around the world.
Earlier this year, Democrat Sen. Diane Feinstein (CA) and Republican Sen. Charles Grassley (IA) urged the Obama administration to “definitively determine if CBD has scientific and medical benefits,” and to “look at expanding compassionate access programs where possible, to benefit as many children as possible.”
Recently, support has also come out from the director of the US National Institute on Drug Abuse (NIDA), Nora Volkow. Volkow believes that cannabidiol (CBD) – a nonpsychotropic cannabinoid – is “a safe drug with no addictive effects.” In a column with The Huffington Post, she further stated that“[P]reliminary data suggest that it may have therapeutic value for a number of medical conditions.”
With all of the talk going on around the country, is there any action behind these promises? […]